84 related articles for article (PubMed ID: 23388733)
1. Influence of fractalkine receptor gene polymorphisms V249I-T280M on cancer occurrence after renal transplantation.
Courivaud C; Bamoulid J; Loupy A; Deschamps M; Ferrand C; Simula-Faivre D; Tiberghien P; Chalopin JM; Legendre C; Thervet E; Borg C; Saas P; Ducloux D
Transplantation; 2013 Mar; 95(5):728-32. PubMed ID: 23388733
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
[TBL] [Abstract][Full Text] [Related]
3. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
[TBL] [Abstract][Full Text] [Related]
4. Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity.
Sirois-Gagnon D; Chamberland A; Perron S; Brisson D; Gaudet D; Laprise C
Obesity (Silver Spring); 2011 Jan; 19(1):222-7. PubMed ID: 20523302
[TBL] [Abstract][Full Text] [Related]
5. T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease.
Hattori H; Ito D; Tanahashi N; Murata M; Saito I; Watanabe K; Suzuki N
Neurosci Lett; 2005 Feb; 374(2):132-5. PubMed ID: 15644279
[TBL] [Abstract][Full Text] [Related]
6. Association study between the CX3CR1 gene and asthma.
Tremblay K; Lemire M; Provost V; Pastinen T; Renaud Y; Sandford AJ; Laviolette M; Hudson TJ; Laprise C
Genes Immun; 2006 Dec; 7(8):632-9. PubMed ID: 17082760
[TBL] [Abstract][Full Text] [Related]
7. Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease.
Yadav AK; Kumar V; Jha V
Indian J Nephrol; 2016; 26(4):275-9. PubMed ID: 27512300
[TBL] [Abstract][Full Text] [Related]
8. Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.
Nassar BA; Nanji AA; Ransom TP; Rockwood K; Kirkland SA; Macpherson K; Connelly PW; Johnstone DE; O'Neill BJ; Bata IR; Andreou P; Title LM
Scand J Clin Lab Invest; 2008; 68(4):286-91. PubMed ID: 18609106
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients.
Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
Int J Colorectal Dis; 2007 Oct; 22(10):1195-200. PubMed ID: 17611763
[TBL] [Abstract][Full Text] [Related]
10. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
Niessner A; Marculescu R; Haschemi A; Endler G; Zorn G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
Thromb Haemost; 2005 May; 93(5):949-54. PubMed ID: 15886814
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between CX3CR1 V249I and T280M polymorphisms and risk of Parkinson's disease in a Greek population.
Kalinderi K; Bostantjopoulou S; Katsarou Z; Clarimón J; Fidani L
Genet Test Mol Biomarkers; 2012 Aug; 16(8):974-7. PubMed ID: 22747084
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma.
Mühlbauer M; Ringel S; Hartmann A; Lallinger G; Weiss TS; Gäbele E; Wünsch PH; Schölmerich J; Hellerbrand C
Oncol Rep; 2005 May; 13(5):957-63. PubMed ID: 15809764
[TBL] [Abstract][Full Text] [Related]
13. The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.
Wasmuth HE; Zaldivar MM; Berres ML; Werth A; Scholten D; Hillebrandt S; Tacke F; Schmitz P; Dahl E; Wiederholt T; Hellerbrand C; Berg T; Weiskirchen R; Trautwein C; Lammert F
J Hepatol; 2008 Feb; 48(2):208-15. PubMed ID: 18078680
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension.
Marasini B; Cossutta R; Selmi C; Pozzi MR; Gardinali M; Massarotti M; Erario M; Battaglioli L; Biondi ML
Clin Dev Immunol; 2005 Dec; 12(4):275-9. PubMed ID: 16584113
[TBL] [Abstract][Full Text] [Related]
15. Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis.
Bagci B; Bagci G; Huzmeli C; Sezgin I; Ozdemir O
Int Urol Nephrol; 2016 Jul; 48(7):1163-70. PubMed ID: 27118566
[TBL] [Abstract][Full Text] [Related]
16. Association of polymorphisms in the chemokine receptor CX3CR1 gene with coronary artery disease.
Matzhold EM; Trummer O; Grünbacher G; Zulus B; Boehm BO; März W; Renner W
Cytokine; 2009 Sep; 47(3):224-7. PubMed ID: 19628406
[TBL] [Abstract][Full Text] [Related]
17. The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.
Stojković L; Djurić T; Stanković A; Dinčić E; Stančić O; Veljković N; Alavantić D; Zivković M
J Neuroimmunol; 2012 Apr; 245(1-2):87-92. PubMed ID: 22261545
[TBL] [Abstract][Full Text] [Related]
18. T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis.
Amanatidou V; Sourvinos G; Apostolakis S; Tsilimigaki A; Spandidos DA
Pediatr Infect Dis J; 2006 May; 25(5):410-4. PubMed ID: 16645504
[TBL] [Abstract][Full Text] [Related]
19. Association between the CX3CR1 gene V249I polymorphism and delayed kidney allograft function.
Dabrowska-Zamojcin E; Dziedziejko V; Safranow K; Kurzawski M; Domanski L; Pawlik A
Transpl Immunol; 2015 Jun; 32(3):172-4. PubMed ID: 25898802
[TBL] [Abstract][Full Text] [Related]
20. Association of V249I and T280M variants of fractalkine receptor CX3CR1 with carotid intima-media thickness in a mexican population with type 2 diabetes.
Gómez-Díaz RA; Gutiérrez J; Contreras-Rodriguez A; Valladares-Salgado A; Tanus-Hajj J; Mondragón-González R; Talavera JO; Mejía-Benitez MA; García-Mena J; Cruz M; Wacher NH
Gac Med Mex; 2017; 153(1):49-56. PubMed ID: 28128806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
